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Table 1
Multivariable analysis comparing quality of life scores
Isolated oral vs. oral and extra-oral Isolated oral vs. only extra-oral
Difference in QOL scores between groups p-value Difference inQOL scoresbetween groups p-value
FACT-BMT
total 3.14 0.03 1.58 0.32
physical well-being 1.09 0.009 1.09 0.02
social/family well-being 0.17 0.63 -0.13 0.75
emotional well-being 0.45 0.14 0.07 0.85
functional well-being 0.88 0.05 0.29 0.56
BMT well-being 1.10 0.01 0.81 0.10
SF-36
PCS 1.20 0.14 1.08 0.23
MCS 0.17 0.85 -0.67 0.50
physical functioning 0.96 0.25 0.79 0.39
physical role functioning -0.29 0.76 -0.52 0.62
bodily pain 2.26 0.01 2.43 0.02
general health perceptions 1.62 0.05 0.22 0.81
vitality 0.07 0.94 -0.50 0.60
social role functioning 1.29 0.21 0.81 0.47
emotional role functioning 0.46 0.67 -0.72 0.54
mental health 0.27 0.75 -0.43 0.64
BMT¼ bone marrow transplant, PCS¼ physical component score, MCS¼ mental component score.
Table 1
Predictors of Preventive Care Adherence (N¼387 in Logistic Regression)
OR (95%CI) P value
Abstracts / Biol Blood Marrow Transplant 21 (2015) S54eS78S78Conclusions: Isolated oral cGVHD is associated with
better QOL compared to extra-oral cGVHD across multiple
domains, in particular physical well-being and bodily pain.Gender <.001
Male referent
Female 4.64 (2.78-7.76)
cGVHD History .002
None-mild referent
Moderate-severe 2.29 (1.37-3.85)
Financial Barriers .03
No referent
Yes 2.30 (1.08-4.90)
Side Effects Barriers .02
No referent
Yes 2.28 (1.15-4.52)
Time Constraints Barriers .02
No referent
Yes 2.25 (1.12-4.52)
SF-36 Physical Component T score 1.03 (1.01-1.06) .01
Conﬁdence in Survivorship Information 0.36 (.21-.60) <.00169
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Introduction: HCT survivors require long-term surveillance
and preventive care to reduce the late effects of treatment.
We examined demographic, treatment and psychosocial
factors associated with preventive care adherence (PCA) in a
national sample of survivors recruited for an online RCT.
Method: Four email invitations to participate were sent to
HCT survivors on the BMT InfoNet listserve, a patient
resource and advocacy site. Eligibility criteria included
18 years old, more than two years post-HCT, without a
recurrence or second cancer in the prior two years, able to
communicate in English, and with internet and email access.
Measures were the Short Form-36 physical component scale
(PCS), Symptom Checklist-90-R depression, Cancer and
Treatment Distress, Katz Comorbidity Index, Conﬁdence in
Survivorship Information (CSI) about recommended PCA
tests for HCT survivors, and Barriers to PCA. Multivariate
logistic regression was used to analyze factors associated
with not meeting PCA criteria for at least 75% of 15 exams.
Results: Of 493 registered survivors, 395 (80%) were eligible
for analysis. Participants were from the U.S. (93%, N¼368)
and 12 other countries, treated at 142 centers, largelyCaucasian and non-Hispanic (94%), on average 9 years
post-HCT (SD¼6, range 2-33); 67% received allogeneic HCT,
38% reported a history of moderate to severe chronic graft
versus host disease (cGVHD). The percentage of survivors
who did not meet recommended criteria on 75% of the 15
potential PCA tests was 37% (N¼147). Age, race and ethnicity,
years post-transplant, comorbidities, depression and
distress were not associated with PCA (P’s >.05). Table 1
indicates the odds ratios and conﬁdence intervals for
factors associated with PCA in the ﬁnal model including:
gender, cGVHD history, SF-36 PCS T scores, CSI, and 3 types
of barriers: ﬁnancial, concerns about side effects, and time
constraints.
Discussion: Over a third of HCT long-term survivors inter-
ested in an online RCT did not meet PCA recommendations,
indicating need for improved dissemination of preventive
guidelines. Those needing targeted approaches to improve
PCA include males, those doing better in physical function
and lack of cGVHD history, and those with deﬁnable barriers
to health care.
